Can Mounjaro cause hair loss? Hair thinning side effects explained

Simon Edward • 3 September 2025

Can Mounjaro cause hair loss? Learn the facts about tirzepatide and hair thinning – and how to manage it.



Can Mounjaro cause hair loss? Learn the facts about tirzepatide and hair thinning – and how to manage it.

Have you noticed extra hairs in the shower or your hairbrush since starting Mounjaro (tirzepatide)? You're not alone.


Hair thinning and shedding are listed as side effects of Mounjaro. However, evidence points to quick weight loss as the cause, rather than direct damage to your hair.


Let's unpack what studies say about hair changes with Mounjaro, why rapid weight loss can trigger shedding and what you can do about it.


Is hair loss a known side effect of tirzepatide?

Yes, but context matters.


In pooled obesity trials, reports of hair shedding with tirzepatide were linked to weight loss and were more common in women than men:


People taking tirzepatide People taking a placebo (dummy drug)
7.1% of women experienced hair loss 1.3% of women experienced hair loss
0.5% of men experienced hair loss 0% of men experienced hair loss

Interestingly, no one on tirzepatide stopped treatment because of hair loss, while one person on placebo did.


A similar pattern appears with semaglutide (Wegovy). In EU product information for Wegovy, hair loss was reported in 2.5% of patients on semaglutide versus 1% on placebo. Most cases were mild and occurred more often in people who lost at least 20% of their body weight.


Why can weight loss trigger shedding?

The important thing to know is that Mounjaro does not directly cause hair loss. Instead, hair shedding occurs because of changes in the body triggered by weight loss.


The most likely cause is telogen effluvium. This condition can occur after a significant stress on the body, causing more hairs than usual to move into a resting phase. A few months later, this will cause extra shedding.


Common triggers include illness, big life changes and rapid weight loss or strict dieting. As your weight and nutrition settle, shedding usually eases, and your hair should grow back.


Picture of healthy hair.

In other words, hair loss with tirzepatide is usually temporary and linked to the stress your body is under. It's not because of any lasting damage to your hair follicles.


Practical steps to lower the risk

  • Aim for steady weight loss and avoid crash dieting.
  • Prioritise protein and include iron, zinc and vitamin D-rich foods.
  • Keep stress in check and make sure you get enough sleep.
  • Be gentle with your hair care routine.


When to seek medical advice

Book an appointment with your healthcare provider or talk to the SemaPen team if:

  • You're worried about hair loss, or the shedding hasn't eased after a few months
  • You notice patchy bald areas or a quickly widening parting
  • You experience scalp pain, itching, scaling or redness
  • Hair loss comes with other symptoms such as fatigue, rapid and unexplained weight change or changes to your menstrual cycle

Your healthcare team can check for treatable causes (such as low iron or thyroid problems) and advise on next steps.


SemaPen: a safe, steady way to use Mounjaro

At SemaPen, we prescribe Mounjaro within a structured medical weight loss plan. That means you're supported from day one.

You start with an online consultation reviewed by a UK-registered prescriber. If we feel our treatment is safe and appropriate for you, we provide:


  • Ongoing clinical monitoring to keep your rate of weight loss steady
  • Nutrition guidance so that protein and key micronutrients are covered
  • Smart scale integration and regular check-ins
  • Clear safety information and quick access to help if you encounter side effects

Want to find out if our weight loss programmes could help you? You can get started today by taking our simple online consultation.


Sources


1. Eli Lilly and Company (2023) United States prescribing information: Zepbound. 4.0-ZEP-0000-PEN-IFU-YYYYMMDD. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf


2. European Medicines Agency (2025) European Public Assessment Report (EPAR) for Wegovy. Retrieved from https://www.ema.europa.eu/en/documents/product-information/wegovy-epar-product-information_en.pdf


This article was reviewed and approved by Alice Fletcher, Lead Bariatric Dietitian, on 1 September 2025.


  • Average 15–21% weight loss
  • Trusted programmes built by UK experts
  • Personalised advice and support
  • Smart weight loss app to track progress and learn positive habits

Your journey starts in the app

Unlock tailored support, weight tracking and more.

1

Download the free app

2

Take your digital consultation

3

Start your programme

Download the app
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks
by Simon Edward 31 January 2026
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks in people with chronic kidney disease.
Excess weight can increase the risk of heart problems. Could Mounjaro injections help?
by Simon Edward 31 January 2026
Excess weight can increase the risk of heart problems. Could Mounjaro injections help? Explore the key findings of the SUMMIT clinical trial.
Weight loss diets have been around since at least the mid-1800s.
by Simon Edward 31 January 2026
Weight loss diets have been around since at least the mid-1800s. But does this old-timey advice stand up today? Let's find out.
Is it safe to take weight loss injections during Ramadan or while fasting intermittently?
by Simon Edward 31 January 2026
Is it safe to take weight loss injections during Ramadan or while fasting intermittently? Learn what experts say and what precautions to take.
Unscrupulous and unregulated Wegovy sellers are everywhere. Learn the risks
by Simon Edward 30 January 2026
Unscrupulous and unregulated Wegovy sellers are everywhere. Learn the risks and how to keep yourself safe.
A new weight loss pill helped Wegovy users maintain 95% of their weight loss
by Simon Edward 26 January 2026
A new weight loss pill helped Wegovy users maintain 95% of their weight loss after they stopped taking injections. Let's investigate.
A new, higher dose of Wegovy saw patients achieve nearly 21% weight loss – and it's just won
by Simon Edward 23 January 2026
A new, higher dose of Wegovy saw patients achieve nearly 21% weight loss – and it's just won UK approval. Find out what this means for you.
Results are in for retatrutide, orforglipron and CagriSema. But are they as effective as Wegovy an
12 January 2026
Results are in for retatrutide, orforglipron and CagriSema. But are they as effective as Wegovy and Mounjaro? Find out in our guide.
9 January 2026
Are New Year's resolutions doing more harm than good? Some experts say yes. Learn why and explore healthier ways to stay motivated.
5 January 2026
A recent article suggested Wegovy and Mounjaro cause muscle loss equivalent to 10 years of ageing. Is that true? Get the full facts in our guide.
More posts